24 studies found for:    "Ovarian low malignant potential tumor"
Show Display Options
Rank Status Study
1 Active, not recruiting Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
Conditions: Fallopian Tube Cancer;   Primary Peritoneal Cavity Cancer;   Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor;   Recurrent Ovarian Epithelial Cancer;   Stage III Borderline Ovarian Surface Epithelial-stromal Tumor;   Stage III Ovarian Epithelial Cancer;   Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor;   Stage IV Ovarian Epithelial Cancer
Intervention: Drug: belinostat
2 Active, not recruiting Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
Conditions: Borderline Ovarian Surface Epithelial-stromal Tumor;   Ovarian Serous Cystadenocarcinoma;   Primary Peritoneal Cavity Cancer;   Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
Interventions: Drug: selumetinib;   Other: pharmacological study;   Other: laboratory biomarker analysis
3 Completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Conditions: Advanced Adult Primary Liver Cancer;   Carcinoma of the Appendix;   Estrogen Receptor-negative Breast Cancer;   Extensive Stage Small Cell Lung Cancer;   Gastrointestinal Stromal Tumor;   HER2-negative Breast Cancer;   Metastatic Gastrointestinal Carcinoid Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Progesterone Receptor-negative Breast Cancer;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Primary Liver Cancer;   Recurrent Anal Cancer;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Colon Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Esophageal Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Extrahepatic Bile Duct Cancer;   Recurrent Gallbladder Cancer;   Recurrent Gastric Cancer;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Pancreatic Cancer;   Recurrent Prostate Cancer;   Recurrent Rectal Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Small Cell Lung Cancer;   Recurrent Small Intestine Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Small Intestine Adenocarcinoma;   Small Intestine Leiomyosarcoma;   Small Intestine Lymphoma;   Stage IV Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IV Anal Cancer;   Stage IV Basal Cell Carcinoma of the Lip;   Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Esophageal Cancer;   Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Gastric Cancer;   Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Oropharynx;   Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage IV Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Pancreatic Cancer;   Stage IV Prostate Cancer;   Stage IV Rectal Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer;   Triple-negative Breast Cancer;   Unresectable Extrahepatic Bile Duct Cancer;   Unresectable Gallbladder Cancer;   Unspecified Adult Solid Tumor, Protocol Specific;   Untreated Metastatic Squamous Neck Cancer With Occult Primary
Interventions: Drug: 7-hydroxystaurosporine;   Drug: irinotecan hydrochloride;   Other: diagnostic laboratory biomarker analysis
4 Completed Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Drug: imatinib mesylate
5 Unknown  Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
6 Completed Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
Conditions: Cervical Cancer;   Ovarian Cancer;   Sarcoma
Interventions: Other: counseling intervention;   Other: study of socioeconomic and demographic variables
7 Completed LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
Conditions: Bladder Cancer;   Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Ovarian Cancer;   Pancreatic Cancer
Intervention: Biological: LMB-9 immunotoxin
8 Completed Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Conditions: Bladder Cancer;   Breast Cancer;   Colorectal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Leukemia;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: tanespimycin
9 Completed BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer
Conditions: Breast Cancer;   Ovarian Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: ixabepilone
10 Completed Chemotherapy in Treating Patients With Solid Tumors
Conditions: Bladder Cancer;   Breast Cancer;   Colorectal Cancer;   Esophageal Cancer;   Head and Neck Cancer;   Kidney Cancer;   Lung Cancer;   Ovarian Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: oblimersen sodium;   Drug: docetaxel
11 Completed Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: radionuclide imaging;   Radiation: indium In 111 folic acid
12 Completed Gefitinib in Treating Patients With Cervical Cancer
Conditions: Cervical Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: gefitinib;   Other: immunohistochemistry staining method;   Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry;   Procedure: biopsy;   Procedure: sentinel lymph node biopsy
13 Completed Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Conditions: Bladder Cancer;   Breast Cancer;   Carcinoma of Unknown Primary;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Sarcoma
Interventions: Biological: filgrastim;   Drug: docetaxel;   Drug: gemcitabine hydrochloride
14 Completed Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Conditions: Head and Neck Cancer;   Lung Cancer;   Ovarian Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: cisplatin;   Drug: lurtotecan liposome
15 Completed Immunotoxin Therapy in Treating Patients With Advanced Cancer
Conditions: Cervical Cancer;   Fallopian Tube Cancer;   Head and Neck Cancer;   Lung Cancer;   Malignant Mesothelioma;   Ovarian Cancer;   Pancreatic Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Biological: SS1(dsFv)-PE38 immunotoxin
16 Completed Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
Conditions: Breast Cancer;   Head and Neck Cancer;   Lung Cancer;   Ovarian Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: docetaxel
17 Unknown  Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
Conditions: Bladder Cancer;   Brain and Central Nervous System Tumors;   Carcinoma of Unknown Primary;   Extragonadal Germ Cell Tumor;   Head and Neck Cancer;   Kidney Cancer;   Lung Cancer;   Ovarian Cancer;   Sarcoma;   Testicular Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: filgrastim;   Drug: amifostine trihydrate;   Drug: carboplatin;   Drug: etoposide;   Drug: ifosfamide;   Procedure: peripheral blood stem cell transplantation
18 Completed
Has Results
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma;   Thromboembolism;   Vaginal Cancer;   Vulvar Cancer
Intervention: Drug: fondaparinux sodium
19 Unknown  Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Condition: Cancer
Interventions: Drug: capecitabine;   Drug: chemotherapy;   Radiation: radiation therapy
20 Unknown  Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Condition: Cancer
Intervention: Dietary Supplement: glutamine

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years